Based on 19 analysts giving stock ratings to Janux Therapeutics Inc in the past month.
In the current month, JANX has received 9 Buy Ratings, 2 Hold Ratings, and 1 Sell Ratings. JANX average Analyst price target in the last month is 36.389.
Based on analysts' estimates, JANX EPS is projected to reach -0.529 in FY2026Q4, following reported EPS of -0.342 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.34, while Janux Therapeutics IncJANX's earnings per share (EPS) for the previous quarter was USD -0.35. EPS for the next quarter is expected at USD -0.53.